Table 2 Wholesale acquisition cost of direct-acting antivirals
Direct-acting antiviral | Pharmaceutical company | WAC for 12 week course |
|---|---|---|
Sofosbuvir (Sovaldi) | Gilead sciences | $84,000 |
Ledipasvir/Sofosbuvir (Harvoni) | Gilead sciences | $94,500 |
Ombitasvir/paritaprevir/ritonavir + Dasabuvir (Viekira Pak) | AbbVie | $83,319 |
Daclatasvir (Daklinza) + Sofosbuvir (Sovaldi) | Bristol-Myers Squibb and Gilead | $147,000 |
Grazoprevir/Elbasvir (Zepatier) | Merck | $54,600 |